Back
Global X NASDAQ 100 Covered Call ETF Vs. Bright Minds Biosciences, Inc. Sector Stock Comparison
Buy
58
QYLD
Global X NASDAQ 100 Covered Call ETF
Last Price:
$17.68
Seasonality Move:
-2.58%
Buy
59
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$83.39
Seasonality Move:
-24.59%
Buy
58
Global X NASDAQ 100 Covered Call ETF (QYLD)
is a Buy
Is Global X NASDAQ 100 Covered Call ETF a Buy, Sell or Hold?
-
The current Global X NASDAQ 100 Covered Call ETF [QYLD] share price is $17.67. The Score for QYLD is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
-
QYLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Bright Minds Biosciences, Inc. (DRUG)
is a Buy
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.04. The Score for DRUG is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
DRUG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QYLD Stock Price Chart
What is Global X NASDAQ 100 Covered Call ETF's stock price today?
-
The Global X NASDAQ 100 Covered Call ETF share price today is $17.67Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QYLD is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.
QYLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.92 | Buy |
| Relative Strength Index (14 RSI): | 58.34 | Buy |
| Chaikin Money Flow: | -4961318 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.46 - 17.68) | Buy |
| Bollinger Bands (100): | (16.86 - 17.52) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.39 | Buy |
| Relative Strength Index (14 RSI): | 51.06 | Buy |
| Chaikin Money Flow: | 3906 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (70.36 - 86.3) | Sell |
| Bollinger Bands (100): | (44.73 - 72.77) | Buy |
QYLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.7 | Sell |
| 20-day SMA: | 17.61 | Buy |
| 50-day SMA: | 17.47 | Buy |
| 200-day SMA: | 16.85 | Buy |
| 8-day EMA: | 15.86 | Buy |
| 20-day EMA: | 10.51 | Buy |
| 50-day EMA: | 5.35 | Buy |
| 200-day EMA: | 1.52 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 80.59 | Sell |
| 20-day SMA: | 81.3 | Sell |
| 50-day SMA: | 68.25 | Buy |
| 200-day SMA: | 44.64 | Buy |
| 8-day EMA: | 80.24 | Sell |
| 20-day EMA: | 78.78 | Sell |
| 50-day EMA: | 70.62 | Buy |
| 200-day EMA: | 49.86 | Buy |
Global X NASDAQ 100 Covered Call ETF Earnings Growth & QYLD Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.72 per share, a decrease next quarter of $0.00 per share, a decrease this year of $3.14 per share, and a decrease next year of $1.09 per share.
Global X NASDAQ 100 Covered Call ETF Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||